Development of the retinoic acid receptor alpha-specific antagonist YCT-529 for male contraception: A brief review

Keyphrases

• Male Contraception 100%
• Retinoic Acid Receptor 100%
• Infertility 33%
• α-antagonist 33%
• Pharmacokinetics 16%
• Genetic Studies 16%
• Clinical Development 16%
• In Vivo Efficacy 16%
• Spermatogenesis 16%
• Contraceptives 16%
• Pharmacological Inhibitors 16%
• Male Infertility 16%
• Selective Antagonist 16%
• α-selective 16%
• Testicular Degeneration 16%
• Drug Discontinuation 16%
• Fertility Recovery 16%

Medicine and Dentistry

• Retinoic Acid Receptor Alpha 100%
• Receptor 16%
• Spermiogenesis 16%
• Pharmacokinetics 16%
• Male Infertility 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Retinoic Acid Receptor Alpha 100%
• Receptor 16%
• Male Infertility 16%
• Pharmacokinetics 16%